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Twin pairs discordant for disease may help elucidate the epigenetic mechanisms and causal environmental
factors in disease development and progression. To obtain the numbers of pairs, especially monozygotic
(MZ) twin pairs, necessary for in-depth studies while also allowing for replication, twin studies worldwide
need to pool their resources. The Discordant Twin (DISCOTWIN) consortium was established for this goal.
Here, we describe the DISCOTWIN Consortium and present an analysis of type 2 diabetes (T2D) data in
nearly 35,000 twin pairs. Seven twin cohorts from Europe (Denmark, Finland, Norway, the Netherlands,
Spain, Sweden, and the United Kingdom) and one from Australia investigated the rate of discordance
for T2D in same-sex twin pairs aged 45 years and older. Data were available for 34,166 same-sex twin
pairs, of which 13,970 were MZ, with T2D diagnosis based on self-reported diagnosis and medication use,
fasting glucose and insulin measures, or medical records. The prevalence of T2D ranged from 2.6% to
12.3% across the cohorts depending on age, body mass index (BMI), and national diabetes prevalence.
T2D discordance rate was lower for MZ (5.1%, range 2.9–11.2%) than for same-sex dizygotic (DZ) (8.0%,
range 4.9–13.5%) pairs. Across DISCOTWIN, 720 discordant MZ pairs were identified. Except for the
oldest of the Danish cohorts (mean age 79), heritability estimates based on contingency tables were
moderate to high (0.47–0.77). From a meta-analysis of all data, the heritability was estimated at 72% (95%
confidence interval 61–78%). This study demonstrated high T2D prevalence and high heritability for T2D
liability across twin cohorts. Therefore, the number of discordant MZ pairs for T2D is limited. By combining
national resources, the DISCOTWIN Consortium maximizes the number of discordant MZ pairs needed for
in-depth genotyping, multi-omics, and phenotyping studies, which may provide unique insights into the
pathways linking genes to the development of many diseases.
 Keywords: discordant twins, international comparison, type 2 diabetes, heterogeneity, prevalence
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Type 2 Diabetes Within the DISCOTWIN Consortium
Twin studies have been instrumental in determining the
extent to which genes and environment influence individ-
ual differences for a wide array of diseases and disease-
related traits, as well as for many normal behaviors and
traits. Twin registers have been established to create a more
long-term and stable framework for research (Hur & Craig,
2013), aimed at elucidating genetic and environmental in-
fluences on health and development. In recognition of the
need for collaboration, there has been increased network-
ing of twin study groups, as illustrated by the International
Network of Twin Registries (Buchwald et al., 2014). Twin
data are also useful in collaborations that involve non-twin
samples. For example, twin data have been included in
many consortia and genome-wide association (GWA) stud-
ies, often providing the largest numbers within the GWA
consortia.
Recent advances in molecular and omic methodologies
have greatly increased the utility of the twin design for
uncovering mechanisms and pathways that underlie dis-
ease development (van Dongen et al., 2012). Comparing
MZ twins who are discordant for a particular trait or dis-
ease provides a unique case-control study, where the cases
and controls are matched perfectly for age, sex, and ge-
netic background, as well as for the influence of in utero
and early environmental factors known to affect health and
developmental trajectories. Not only may these compar-
isons provide insight into the influence of, for example,
differential exposures, behavioral choices and life events,
but when DNA is available for the twins, the contribution
of epigenetic factors may also be explored. Despite the full
identity of the genomic sequence in twins from MZ pairs,
MZ twins often differ in concordance for complexly deter-
mined health and behavioral outcomes, such as diabetes,
cancer, cardiovascular disease, or mental health. Epigenetic
factors are one possiblemechanism that could explain these
intra-pair differences. The addition of data from DZ DIS-
COTWINpairs andother familymembershelps to elucidate
the causal directions within those pathways (deMoor et al.,
2008; Kujala et al., 2002).
Scarcity of discordant pairs is the main hindrance to
more prominent use of the co-twin control design. For
any given disease or trait under study, the number of dis-
cordant MZ twin pairs is often limited as a function of
heritability and with increasing prevalence of the disor-
der (Smith, 1970). As in genome-wide association studies
(GWAS) consortia, collaboration is the best way to increase
numbers, such that fully powered epigenetic studies are
possible. Many of twin registers already have strong con-
nections, in particular the European and Australian twin
registers, which as part of the fifth European Framework
Program (Quality of Life andManagement of the LivingRe-
sources, 1998–2002; European Commission, 2004) worked
together within the GenomEUtwin consortium (Peltonen
&GenomEUtwin, 2003). This collaboration led to the pub-
lication of comparative twin analyses for various traits, in-
cluding body composition (Kettunen et al., 2009; Perola
et al., 2007; Schousboe et al., 2003; Silventoinen et al., 2003),
exercise participation (Stubbe et al., 2006; Vink et al., 2011),
migraine (Mulder et al., 2003), subarachnoid hemorrhage
(Korja et al., 2010), and cholesterol (Surakka et al., 2012).
With this past collaborative success in mind, a new twin
consortium has now been created specially focusing on dis-
cordant twins: the DISCOTWIN consortium. In addition
to extensive longitudinal data on health and lifestyle, infor-
mation on biomarkers, and genotypic information is also
available within these cohorts, enabling the study of the ef-
fect of unique environmental influences aswell as epigenetic
studies.
As a demonstration project, we examined twin discor-
dance for T2D. T2D is a complex disease, caused by insuffi-
cient pancreatic beta-cell action and/or progressive insulin
resistance, and related to increasing adiposity, inactivity,
and age (McCarthy, 2010). It leads to a significantly re-
duced life expectancy and, due to its chronicmulti-systemic
comorbidity, is a massive drain on healthcare resources
(Zimmet et al., 2001). In 2014, the World Health Orga-
nization (WHO, 2015) estimated the global prevalence of
diabetes to be 9% among adults aged 18 years or over,
with 90% of these due to T2D (http://www.who.int/
mediacentre/factsheets/fs312/en/). The dramatic increase
in prevalence of T2D in the last 50 years is strongly driven
by the rise of the modern ‘obesogenic’ environment, with
the associated rapid upsurge in obesity due to the combined
effects of reduced physical activity and increased access to
high calorific foods (Friedman, 2009). These serious esca-
lating T2D prevalence rates, while first appearing in devel-
opedWestern nations, are now rapidly emerging within the
developing world as they increasingly adopt modern urban
lifestyles (Gluckman et al., 2011). Heritability plays a role in
T2D, with estimates from twin and family studies ranging
from 25% up to 69%, depending upon age and glycemic
cut-offs (Almgren et al., 2011; Poulsen et al., 1999). GWAS
have now confirmed 92 common single nucleotide poly-
morphism (SNP) T2D-risk associations, including genes
potentially implicated in both insulin secretion and insulin
resistance, aswell as unknownmechanismsof pathogenicity
(Bonnefond & Froguel, 2015).
For adequate prevention and treatment protocols, more
insight into the pathways fromgenes to T2Ddevelopment is
needed. The use of twin-pairs discordant for T2D presents
a unique way to disentangle environmental, genetic, and
epigenetic causes of the disease. Concordance rates for T2D
have been estimated in numerous studies over the years, and
these have varied for multiple possible reasons, including
gene pool differences, regional variation, the influence of a
changing prevalence over time, age at comparison, as well as
different diagnostic criteria. In an early study to distinguish
between T1D and T2D, as opposed to previous childhood-
and adult-onset diabetes categories, Barnett et al. (1981)
observed 48 of 53 (90.6%) MZ twin pairs to be concor-
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dant for T2D in the United Kingdom. In 1987, an American
study estimated an MZ concordance rate of 58% for the
National Heart, Lung, and Blood Institute Twin Study, with
apopulation-expectedprevalence at that timeof 10%(New-
man et al., 1987), while a Japanese study (Committee onDi-
abetic Twins, 1988) showed that for 83% of MZ twins with
T2D, their co-twin could also be diagnosed, while this was
only 40% in the DZ twins. Subsequently, in a Finnish study
including 505 twins, Kaprio et al. (1992) found a proband-
wise 34% and pairwise 20% MZ concordance, compared
to 16% and 9% respectively in DZ twins. In the United
Kingdom, MZ concordance rates for twin pairs who were
initially ascertained as disease-discordant, were 17%, 33%,
57%, and 76% after 1, 5, 10, and 15 years of follow-up,
respectively (Medici et al., 1999), clearly demonstrating the
effect of age andnecessity for significant follow-up.Thecon-
cordance rate was 96% when twins were classified for any
glucose abnormality by 15 years. More recent data gathered
in 2010 from a Finnish population-based study encompass-
ing 1,332 twins (MZ and DZ) who developed T2D showed
a similar pattern of concordance as for the earlier Finnish
study, with 41%probandwise and 34%pairwise forMZ and
19% probandwise and 12% pairwise for DZ twins. Over the
follow-up period of up to 28 years, 50% of MZ co-twins
subsequently became type 2 diabetic while the rate for DZ
was approximately one third (Lehtovirta et al., 2010). At
present, few studies have applied the discordant design to
T2D. Using a longitudinal discordant design, Kujala et al.
(2000) showed that lifestyle factors may influence a genetic
pre-disposition for diabetes, as physically active twins de-
veloped diabetes less often than their sedentary co-twins.
Ribel-Madsen et al. (2012) observed small quantitative dif-
ferences inDNAmethylation in skeletalmuscle and adipose
tissue in T2D discordantMZ twins, while Bork-Jensen et al.
(2015) found differences in T2D discordantMZ pairs in the
regulation of several microRNAs. Furthermore, acquired
obesity has been shown to significantly contribute to in-
sulin resistance and pre-diabetes in weight-discordant MZ
twin pairs (Naukkarinen et al., 2012).
Here, we examine the T2D prevalence, concordance pat-
tern, and heritability in same-sex twin pairs aged 45 years
and older, in twin cohorts from seven European countries
(Denmark, Finland, Norway, the Netherlands, Spain, Swe-
den, and the United Kingdom) and from Australia, and
identify T2D discordant MZ twin pairs for future in-depth
genotyping, omics, and phenotyping studies.
Materials and Methods
Participants and Cohorts
Table 1 provides an overview of the number of complete
twin pairs available for each of the twin cohorts, as well
as their average age. All cohorts that provided data for this
paper have been described in detail elsewhere, but a brief
description of each register is provided below. TA
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Type 2 Diabetes Within the DISCOTWIN Consortium
TheOlder Australian Twins Study (OATS) is a multicenter,
longitudinal study that commenced in 2007. Study partic-
ipants are identical and non-identical twin pairs aged 65
years and older living in the three eastern states of Australia
who completed a comprehensive face-to-face assessment,
including data on demographic, psychiatric, neuropsycho-
logical, andmedicalmeasures. The initial cohort comprised
623 individuals (including 284 twin pairs), and 450 partic-
ipants completed a follow-up assessment at two years. For
the majority of participants, DNA was extracted from pe-
ripheral blood samples and/or saliva samples. For more
details, see Sachdev et al. (2013).
The Longitudinal Study of Aging Danish Twins (LSADT)
is a longitudinal survey among Danish twins aged 70 years
and older, followed every second year for up to six times
from 1995–2005. In 1995, the twins were aged 75 years or
older, but intake age was progressively decreased to age 70
years in the 1999 survey. A total of 4,731 twins have com-
pleted an intake LSADT assessment comprising 1,152 pairs.
Approximately 80%of the participants have provided blood
spots and 689 twins, comprising 290 same-sexed pairs, pro-
vided full blood samples in 1997 (Skytthe et al., 2013). The
data in the present study were based on intact pairs who
participated in survey 2005.
The Danish Twin Register Omnibus Project (‘Omnibus
2002’) is a longitudinal survey among the twin birth co-
horts 1953–1982 from the population-based Danish Twin
Registry. Participants received a nationwide questionnaire
about physical health and health-related behavior in 1994
and a follow-up survey in 2002. As most of the participants
reported no diabetes in the 1994 survey, the follow-up from
2002 was used to obtain the numbers of discordant pairs
(Fejer et al., 2006).
The Finnish Twin Cohort Study (FTCS). The older co-
hort of the Finnish Twin Cohort Study consists of same-sex
twin pairs born before 1958 and initially recruited in 1975.
Follow-up questionnaires have been sent in 1981, 1990,
and 2011 (Kaprio, 2013), and the twins have been linked to
national medical registers (hospital discharge, medication,
and cause-of-death data). Information from these regis-
ters, hospital charts, and questionnaire surveys were used
to identify and classify twins with diabetes and the type of
diabetes. Cases up to the end of 2004 were identified. For
details, see Lehtovirta et al. (2010).
The Norwegian twin registry study on social factors and
health (NTR_SFH). The NTR was established in 2009 as
a merger of three major population-based Norwegian Twin
Panels (Nilsen et al., 2012). It is housed at the Norwegian
Institute of Public Health (NIPH) in Oslo. The NTR con-
tains approximately 30,000 consenting twins, covering birth
years 1896–1960 and 1967–1991, and has conducted studies
in several areas including social factors, coronary heart dis-
ease, and its risk factors, mental health, dementia, cancer,
and the epigenetics of autoimmune diseases (Nilsen et al.,
2013). Among its strengths are linkage opportunities with
nationwide health and socio-economic registries. The NTR
data reported here are from a recent study conducted by
Dr Harris on nearly 6,000 twins aged from 40–80 years, to
study social factors and health.
The Adult Netherlands Twin Register (ANTR) is an on-
going twin-family study on health-related behavior that
assesses families with adolescent and (young) adult twins
since 1991 and includes data on more than 22,000 in-
dividuals. Participants are invited every two or three
years to complete a survey that contains questions about
health, lifestyle, personality, and psychopathology. In ad-
dition, participants have been invited to provide DNA.
For more details, see Willemsen et al. (2013) and
http://www.tweelingenregister.org.
The Murcia Twin Registry (MTR) is a population-based
register of adult twins in the region of Murcia, located in
south-east Spain. To date, the MTR has identified 2,281
participants born between 1940 and 1966. Information is
obtained longitudinally by face to face or telephone inter-
views and includes data on demographics, health, lifestyle,
and related variables. In addition, biological samples (DNA)
have been collected in a subset of the sample. For more de-
tails, see Ordonˇana et al. (2013).
The ScreeningAcross the LifespanofTwins Study (SALT).
Data were collected during a computer-assisted telephone
interview between 1998–2002 on Swedish twins born 1958
or earlier. Introductory letters describing the study were
sent to a random sample of approximately 1,000 twin pairs
each month. A checklist of common illnesses, prescription,
and non-prescription medication use was included in the
study, and special emphasiswas put ondiagnostic items that
could determine whether a twin was likely to have a disease
(rather than simply asking the twin whether they have a
disease). Items were presented in a branching format such
that individuals were asked follow-up items (within item
domain) if they responded positively to key introductory
items. In total, 44,919 twin individuals participated in the
SALT study (Lichtenstein et al., 2002; 2006).
The UK adult twin register (TwinsUK). The TwinsUK
Resource is an active, nationwide adult twin registry based
within the Department of Twin Research & Genetic Epi-
demiology, at the St. Thomas’ Hospital campus, King’s Col-
lege London. The resource recruits voluntary MZ and DZ
same-sex twins throughout the country via media drives,
and the registry currently has 13,000 registered twins.
These twins are predominantly healthy, female (83%), with
equal numbers of MZ (51%) and DZ (49%), and mostly
middle-aged and older (range 18–103; mean 61 years). The
database has an extensive range of phenotypes obtained
via questionnaires, and over 7,000 have attended detailed
TWIN RESEARCH AND HUMAN GENETICS 765
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clinical visits in the department over this period, enabling
blood/urine/tissue sample collection, with many visiting
at multiple time-points from 1992 onwards (700 with
four visits). These resources are used to study the genetic
and environmental etiology of complex diseases, as well as
the healthy aging process (see Moayyeri, Hammond, Hart
et al., 2013; Moayyeri, Hammond, Valdes et al., 2013; and
http://www.twin-research.ac.uk).
Type 2 Diabetes Phenotyping
Data were included if participants were aged 45 years or
over and did not report Type 1 diabetes. T2D was estab-
lished in most cohorts (OATS, ANTR, SALT, NTR_SFH,
TwinsUK) by questions in a survey asking whether a doctor
ever diagnosed diabetes and whether any diabetes-related
medication was used. In some cohorts, additional informa-
tion was available from national/regional health registers
(FTC, MTR, TwinsUK) or fasting blood glucose and/or in-
sulin levels (OATS, ANTR). The exceptions were theDanish
cohorts (LSADT, Omnibus 2002) where participants were
asked to indicated whether they had diabetes with no dis-
tinction of type.
Analyses
Descriptive and genetic analyses were based on summary
data on prevalence and twin concordance and discordance,
provided by the individual cohorts. Meta-analysis of the
concordance data was carried out using structural equation
modeling in Mx (Neale et al., 2003). Data on the number
of pairs concordant and discordant for T2D were the basis
to estimate tetrachoric correlations for MZ and DZ twins,
assuming an underlying normal liability distribution (Fal-
coner & Mackay, 1996), where the two categories are the
result of a cut-off or threshold reflecting the prevalence of
the trait (i.e., above the threshold T2D is indicated). Next,
the contribution of additive genetic (A), common envi-
ronmental (C), and unique environmental (E) influences
to the variance in T2D liability was estimated by specify-
ing a model in which A factors are correlated unity in MZ
twin pairs and in DZ twins 0.50. Common environmental
factors are correlated one in MZ and DZ twin pairs. The
contribution of unique environment is obtained by con-
straining the sum of the squared path loadings due to A,
C, and E to unity (Rijsdijk & Sham, 2002). The number
of estimated parameters within the model is three (one
threshold and two path loadings). To test for heterogeneity,
data from all cohorts were simultaneously analyzed. First,
estimates for thresholds and path loadings were allowed
to differ and next, path loadings were constrained to be
equal across the cohorts. Within this model, 11 parameters
(nine thresholds and two path loadings) were estimated.
At a difference of 16 degrees of freedom (comparing the
combined model with 11 parameters to the sum of the
nine individual models with three parameters each), het-
erogeneity is implied if the difference in chi-square between
the model and the total of the individual cohort models
exceeds 26.296.
Results
Table 1 shows the distribution of the total number of twin
pairs (34,166 pairs) across the participating cohorts. In ad-
dition, the table provides the national prevalence and the
comparative prevalence (the prevalence adjusted for the age
profile of the nation) for each of the countries involved, as
obtained from the International Diabetes Federation (IDF,
2015), and the cohort prevalence, as calculated based on the
occurrence of diabetes in the same-sex twin pairs. The T2D
prevalence data show a clear increase with age and BMI for
T2D, but also reveal country differences, with Spain show-
ing the highest and theUnited Kingdom showing the lowest
ratesofdiabetes.The twincohortprevalencebroadly reflects
the pattern that is seen in the standardized figures from the
IDF, though some cohorts may have increased or decreased
rates, possibly due to the age range of the participants or
the varying criteria used for diagnosis.
Table 2 provides information on the number of MZ and
DZ pairs and the rates of T2D concordance and discor-
dances by country. Overall, the majority of the twin pairs
(87.6–97.2%) are concordant for not having T2D, and the
concordance rates for having T2D are lower than for being
T2D discordant. The T2D discordance rates differ across
the cohorts, ranging from 2.9–11.2% for the MZ pairs and
from 4.9–13.5% in same-sex DZ pairs, while discordance
rates are always lower in MZ than in DZ twin pairs in all
countries. Collectively, there are 716 (5.1%) discordant MZ
twin and 1,619 (8.0%) discordant same-sex DZ twin pairs.
Cohorts with more old age individuals and a higher T2D
prevalence contribute relativelymore to the number of T2D
discordant pairs.
Collectively, there are 716 (5.1%) discordant MZ twin
and 1,619 (8.0%) discordant same-sex DZ twin pairs. Co-
hortswithmoreold age individuals and ahigherT2Dpreva-
lence contribute relatively more to the number of T2D dis-
cordant pairs.
Table 3 presents the results of genetic analyses. The MZ
correlations are remarkably similar across the cohorts, with
six of the eight correlations ranging within 0.72–0.78, and
while the DZ correlations show more variation, five of the
eight are within the range of 0.36–0.47. With respect to the
ACE modeling, again a consistent pattern emerges. In all
cohorts but LSADT, there is moderate to high heritability
in the liability to T2D, with estimations for the larger co-
horts ranging from 64% to 79%. The influence of common
environment is only suggested in the smaller cohorts, where
the large confidence intervals indicate the uncertainty about
these estimates. When analyzing all cohort data simultane-
ously and equating the path loadings from the ACE factors,
the chi-square for the model was 31.31. The chi-square
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TABLE 2
The Number and Percentage of Twin Pairs Concordant and Discordant for Having T2D Diabetes for Each of the Cohorts
Concordant no. T2D Concordant T2D Discordant T2D
Number of pairs MZ DZ MZ DZ MZ DZ
Cohort MZ DZ N % N % N % N % N % N %
OATS 159 80 135 84.9 68 85.0 8 5.0 2 2.5 16 10.1 10 12.5
LSADT 107 126 92 86.0 102 81.0 3 2.8 7 5.6 12 11.2 17 13.5
Omnibus 2002 1,190 1,895 1,131 95.0 1,775 93.7 15 1.3 7 0.4 44 3.7 113 6.0
FTCS 4,021 8,810 3,613 89.9 7,833 88.9 113 2.8 109 1.2 295 7.3 868 9.9
NTR_SFH 854 839 797 93.3 791 94.3 16 1.9 4 0.5 41 4.8 44 5.2
ANTR 644 247 596 92.5 231 93.5 13 2.0 0 0 35 5.4 16 6.5
MTR 305 322 254 83.3 263 81.7 27 8.9 17 5.3 24 7.9 42 13.0
SALT 4,212 5,840 3,963 94.1 5,389 92.3 72 1.7 42 0.7 177 4.2 409 7.0
TwinsUK 2,478 2,037 2,382 96.1 1,930 94.7 24 1.0 7 0.3 72 2.9 100 4.9
Overall 13,970 20,196 12,963 92.8 18,382 91.0 291 2.1 195 1.0 716 5.1 1,619 8.0
TABLE 3
Twin Correlations, the Percentage Explained Variance by A, C, and E for the Full Model and the Difference in Fit Function Between the
Individual Models and the Combined Model in Which the ACE Estimates Were Equated for the Cohorts
Difference in
Number of pairs Twin correlations ACE fit function
Cohort MZ DZ MZ DZ A C E MZ DZ
OATS 159 80 0.74 (0.46–0.90) 0.47 (-0.10–0.83) 0.51 (0.00–0.90) 0.22 (0.00–0.82) 0.27 (0.10–0.55) 0.05 0.09
LSADT 107 126 0.55 (0.08–0.85) 0.69 (0.37–0.88) 0.00 (0.00–0.69) 0.64 (0.06–0.82) 0.36 (0.14–0.61) 1.05 3.12
Omnibus
2002
1,190 1,895 0.76 (0.61–0.86) 0.29 (0.09–0.48) 0.74 (0.43–0.85) 0.00 (0.00–0.25) 0.26 (0.15–0.40) -0.05 0.48
FTCS 4,021 8,810 0.72 (0.66–0.77) 0.38 (0.32–0.44) 0.66 (0.49–0.77) 0.06 (0.00–0.19) 0.29 (0.24–0.34) 2.27 0.27
NTR_SFH 854 839 0.76 (0.61–0.87) 0.41 (0.12–0.65) 0.64 (0.08–0.86) 0.11 (0.00–0.61) 0.25 (0.14–0.40) 0.04 0.03
ANTR 644 247 0.74 (0.57–0.86) 0.15 (-0.48–0.67) 0.73 (0.00–0.85) 0.00 (0.00–0.72) 0.27 (0.15–0.45) 0.01 0.20
MTR 305 322 0.89 (0.78–0.95) 0.65 (0.45–0.79) 0.47 (0.11–0.89) 0.42 (0.01–0.72) 0.11 (0.05–0.22) 5.53 5.87
SALT 4,212 5,840 0.78 (0.72–0.83) 0.39 (0.30–0.48) 0.79 (0.58–0.83) 0.00 (0.00–0.18) 0.21 (0.17–0.27) 0.15 0.17
TwinsUK 2,478 2,037 0.77 (0.66–0.85) 0.36 (0.15–0.54) 0.77 (0.43–0.85) 0.00 (0.00–0.30) 0.23 (0.15–0.33) 0.95 0.14
Combined 13,970 20,196 0.76 (0.73–0.79) 0.41 (0.37–0.45) 0.72 (0.61–0.78) 0.04 (0.00–0.13) 0.25 (0.22–0.28) 9.99 10.37
estimates for the individual models added up to 10.95, re-
sulting in a chi-square difference of 20.18 which, at a differ-
ence of 16 degrees of freedom, indicates there is no signif-
icant evidence for heterogeneity. To explore the difference
in chi-square more closely, the difference in fit function be-
tween the individual models and the combined model was
examined (see Table 3): more than 50% of the difference in
chi-square is accounted for by theMTR. Overall, the results
show that additive genetic effects account for the majority
(72%) of the variance in liability to T2D.
Discussion
Although the discordance for T2D within MZ twin pairs is
relatively low, theDISCOTWINconsortium is able, by com-
bining the resources of twin cohorts, to identify a substantial
number of T2D discordant MZ pairs. The collaborative ef-
fort of DISCOTWIN also allows for good estimates of T2D
heritability and MZ concordance, which are needed as the
previous literature has been inconsistent. The data collected
from different countries were surprisingly consistent, with
all cohorts reporting over 87% concordance in MZ pairs,
due mostly to both twins reporting no T2D. When one of
the twins reported T2D, in 20–53% of the MZ pairs the co-
twin also reportedT2D,while this wasmuch lower (0–29%)
for DZ twin pairs. The increasing prevalence of obesity as
the main risk factor for T2Dmay be responsible for further
increases in rates of concordance. In a way, the concordance
rate is perhaps the upper limit for the potential of predictive
strategies for personalizedmedicine, and high concordance
rates for T2D are therefore encouraging for future efforts at
early prediction using omics.
The numbers observed in the EURODISCOTWIN con-
sortium will be sufficient to look at more complex inter-
actions and follow-up on findings by replication and in-
depth analyses. The current overview is pre-dominantly
based on survey data and thus reflects the starting point
for twin pair selection. Most twin registers are able to con-
tact their twin participants for additional phenotyping or
can link to national health register or population databases
to obtain more refined diagnoses. For selected twin pairs,
T2D status can therefore be verified, for instance, by fasting
glucose or glucose tolerance tests, or via doctor diagno-
sis in patient records. A thorough verification of the type
of diagnoses may still be necessary, even when excluding
Type 1 diabetes cases and restricting the sample to age
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45 years and over, as late-onset autoimmune diabetes of
adulthood (sometimes called LADA, slow onset diabetes or
diabetes type 1.5) may occur frequently and is often mis-
takenly taken for T2D (Landin-Olsson, 2002). It should be
noted that the recruitment method and type of data avail-
able may also influence the discordance rates. For instance,
register data may not cover all twins in the population,
while those relying on hospital records will have an under-
representation of cases. When comprehensive medication
data are available (as in the Nordic countries), all medi-
cated cases will be identified, but unless survey data are
available, non-medicated individuals will be missed. Many
non-medicated cases will become registered in the health-
care system and receive medication over time. Hence, mod-
els that take into account the lifecourse and development of
T2D as well as censoring and competing causes of death
will provide more sophisticated estimates of the overall
contribution of genetic factors to the disease. Within the
DISCOTWIN consortium, a wide range of such selection
strategies across the countries are available, with sometimes
the possibility of combining strategies. In addition to the
possibility of follow-up on diagnoses and the acquisition of
new genotypic and phenotypic data in identified pairs, twin
registers generally have already followed their twin partici-
pants for a number of years, thereby allowing investigations
into lifestyle and other behavioral differences in the T2D
discordant pairs, using earlier (longitudinal) data. Estab-
lishing a format for information collection in discordant
twin pairs, once they are identified, will result in an ever-
growing informative database, as more twins reach the age
at which T2D may be expected to develop, with data pre-
ceding and following T2D development. The follow-up of
discordant T2D pairs may be particularly important, since
the non-T2D twin is at increased risk of developing T2D,
as may be evident from the higher T2D concordance in the
older twin cohorts and as documented by Lehtovirta et al.
(2010).
The contingency tables allowed for an estimation of the
heritability that provided a consistent pattern across the co-
horts. Heterogeneity was not implied, and using the com-
bined data the heritability for T2D was estimated at 72%.
This is in line with the upper limit (69%) reported by Alm-
gren et al. (2011) when the age rangewas restricted to 35–60
years. In the present study, data were restricted to twin pairs
who were at least 45 years of age at the time the T2D assess-
ment was obtained, to ensure both twins had a chance to
developT2D. It is likely that age differences contribute to the
differences in heritability estimates for T2D across studies.
The high heritability seen here for our twins further reduces
the chances of identifyingT2DdiscordantMZpairs, thereby
providing additional support for the establishment of the
DISCOTWIN consortium to obtain sufficient numbers for
more in-depth study.
The combination of phenotypic and genotypic informa-
tion, especially when collected longitudinally, in these T2D
discordant pairs can lead to important new insights into
epigenetic processes. With regards to epigenome-wide as-
sociation studies (EWAS), a population-based case-control
methodology encounters significant issues, particularly due
to the inherent power reduction because of the influence of
genetic heterogeneity on the epigenome (Mill & Heijmans,
2013). This genetic confounding effect may be direct, in cis
or trans adding huge complexity, especially if size effects
are small. Leveraging the virtually identical genetic back-
grounds of MZ twins in a disease-discordant model has
thus immense advantages in the hunt for disease-associated
non-genetic factors. Accounting for these confounding ge-
netic effects and additionally many shared environmental
and cohort effects provides significantly greater power than
other study designs (Rakyan et al., 2011), and these com-
bined numbers across the consortium will enable rigorous
replication of small scale positive findings, as well as novel
discoveries to be made. Many other omics technologies
may be applied to disease discordant twins (metabolomics,
transcriptomics, glycomics, metagenomics, proteomics),
providing a complete picture of the processes in-
volved in disease development and progression (Pallister
et al., 2014).
In conclusion, through collaboration, the twin registers
can generate the numbers and data to conduct in-depth
analyses of the (epi)genetic and environmental pathways
that lead to twin differences in disease. With the discordant
twin design as a powerful base, the DISCOTWIN consor-
tium can provide new insights that may lead to prognostic,
predictive, and therapeutic targets for the prevention and
treatment of a wide range of diseases, such as T2D.
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